12/22
03:10 am
nvs
2 Top Stocks to Buy and Hold for the Long Term [Yahoo! Finance]
Low
Report
2 Top Stocks to Buy and Hold for the Long Term [Yahoo! Finance]
12/19
03:17 pm
nvs
Nine Drugmakers Strike Deals With Trump, More Coming Next Year [Yahoo! Finance]
Low
Report
Nine Drugmakers Strike Deals With Trump, More Coming Next Year [Yahoo! Finance]
12/19
03:11 pm
nvs
Novartis and US government reach agreement on lowering drug prices in the US [Yahoo! Finance]
Low
Report
Novartis and US government reach agreement on lowering drug prices in the US [Yahoo! Finance]
12/19
02:59 pm
nvs
Novartis' myasthenia gravis asset iptacopan granted FDA Orphan Drug status [Seeking Alpha]
Low
Report
Novartis' myasthenia gravis asset iptacopan granted FDA Orphan Drug status [Seeking Alpha]
12/19
09:04 am
nvs
Corporate director convicted of insider trading [Investment Executive - News]
Low
Report
Corporate director convicted of insider trading [Investment Executive - News]
12/17
09:29 am
nvs
Alira Health Appoints Dr. Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador [Yahoo! Finance]
Low
Report
Alira Health Appoints Dr. Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador [Yahoo! Finance]
12/17
12:00 am
nvs
???????????????????? : ???????????????2033????559????????????????????????(CAGR)6.25%??????? [CNET News]
Low
Report
???????????????????? : ???????????????2033????559????????????????????????(CAGR)6.25%??????? [CNET News]
12/15
02:36 pm
nvs
FDA commissioner unveils major reform to fast-track drug innovation [FOX Business Network]
Low
Report
FDA commissioner unveils major reform to fast-track drug innovation [FOX Business Network]
12/14
05:24 am
nvs
Has Novartis' 24.5% Surge Left Further Upside After Strong Pipeline and Cash Flow Gains? [Yahoo! Finance]
Low
Report
Has Novartis' 24.5% Surge Left Further Upside After Strong Pipeline and Cash Flow Gains? [Yahoo! Finance]
12/12
07:43 am
nvs
Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report [Yahoo! Finance]
Low
Report
Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report [Yahoo! Finance]
12/12
07:39 am
nvs
Novartis breaks ground on flagship manufacturing hub in North Carolina [Yahoo! Finance]
Low
Report
Novartis breaks ground on flagship manufacturing hub in North Carolina [Yahoo! Finance]
12/12
07:00 am
nvs
Novartis breaks ground on flagship manufacturing hub in North Carolina
Low
Report
Novartis breaks ground on flagship manufacturing hub in North Carolina
12/11
09:30 pm
nvs
Drugmaker Novartis begins work on Research Triangle expansion [Yahoo! Finance]
Low
Report
Drugmaker Novartis begins work on Research Triangle expansion [Yahoo! Finance]
12/11
12:13 pm
nvs
Biopharmaceutical Contract Manufacturing Market to Surpass US$ 100 Billion by 2031 [Yahoo! Finance]
Low
Report
Biopharmaceutical Contract Manufacturing Market to Surpass US$ 100 Billion by 2031 [Yahoo! Finance]
12/11
09:12 am
nvs
Sen-Jam Pharmaceutical Secures Major Strategic Partnership with TASK Clinical to Fund Two-Thirds of Phase 3 Trial for SJP-001 [Yahoo! Finance]
Low
Report
Sen-Jam Pharmaceutical Secures Major Strategic Partnership with TASK Clinical to Fund Two-Thirds of Phase 3 Trial for SJP-001 [Yahoo! Finance]
12/10
11:38 am
nvs
Novartis AG (NVS) Gets Upgraded to Overweight from Neutral by JPMorgan [Yahoo! Finance]
Low
Report
Novartis AG (NVS) Gets Upgraded to Overweight from Neutral by JPMorgan [Yahoo! Finance]
12/10
07:37 am
nvs
Novartis (SWX:NOVN) Valuation After Key Ianalumab Phase III Success and Expanded Itvisma FDA Approval [Yahoo! Finance]
Low
Report
Novartis (SWX:NOVN) Valuation After Key Ianalumab Phase III Success and Expanded Itvisma FDA Approval [Yahoo! Finance]
12/10
07:21 am
nvs
Novartis (NYSE:NVS) had its "reduce" rating reaffirmed by analysts at HSBC Holdings plc.
Low
Report
Novartis (NYSE:NVS) had its "reduce" rating reaffirmed by analysts at HSBC Holdings plc.
12/10
04:10 am
nvs
Novartis (NYSE:NVS) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Novartis (NYSE:NVS) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
12/8
08:35 am
nvs
Novartis (NYSE:NVS) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.
Low
Report
Novartis (NYSE:NVS) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.
12/3
04:32 pm
nvs
Novartis (NYSE:NVS) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Novartis (NYSE:NVS) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
12/3
07:19 am
nvs
Novartis (NYSE:NVS) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Novartis (NYSE:NVS) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/2
10:56 am
nvs
Janux dives as gaps in prostate cancer study data worry investors [Yahoo! Finance Canada]
Low
Report
Janux dives as gaps in prostate cancer study data worry investors [Yahoo! Finance Canada]
12/1
04:32 pm
nvs
Progress In Fight Against Malaria, As New Treatment Shows Promise [Forbes]
Low
Report
Progress In Fight Against Malaria, As New Treatment Shows Promise [Forbes]
11/29
12:31 am
nvs
Low
Report